Tumour-associated carbohydrate antigen (TACA) Tn is always observed on the cell surface of malignant tumour cells. Tn is presented as mucin-type carbohydrate. It has been reported to be associated with cancer progression, but the regulation on Tn expression in cancer cells is not fully understood. In this study, we took an effort to explore the mechanism of how Tn expression is regulated in cancer cells. We observed that Tn expression in cancer cells was decreased by changing to fresh medium every 24 h. If we keep cancer cells in continuous cultured medium, we observed that Tn expression was elevated. We further showed that adding continuous cultured medium to cancer cells which change to fresh medium every 24 hours resulted in an induction of Tn expression. These observations suggest that cancer cells may autocrine some substance to stimulate Tn expression. We have identified at least two cytokines, TNF-α and IL-6, that are autocrined by cancer cells and both cytokines can induce Tn expression. We further demonstrated that the induction of Tn expression can be driven by ras oncogene. This study thus indicates that tumor microenviroment contributed by cancer cell oncogene and by autocrine of cytokines is an important factor in regulation of Tn expression.
. 2014 Nov 6;2(Suppl 3):P170. doi: 10.1186/2051-1426-2-S3-P170
Expression of tumor-associated carbohydrate antigen Tn in cancer cells is stimulated by cytokine secreted from cancer cells
Alex Lin
1, Chiao-en Chen
1, Jaulang Hwang
1,✉
Alex Lin
1Dept. Biochemistry, School of Medicine, Taipei Medical University, Taipei, Taiwan
Find articles by Alex Lin
Chiao-en Chen
1Dept. Biochemistry, School of Medicine, Taipei Medical University, Taipei, Taiwan
Find articles by Chiao-en Chen
Jaulang Hwang
1Dept. Biochemistry, School of Medicine, Taipei Medical University, Taipei, Taiwan
Find articles by Jaulang Hwang
1Dept. Biochemistry, School of Medicine, Taipei Medical University, Taipei, Taiwan
✉
Corresponding author.
Supplement
Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Conference
6-9 November 2014
Society for Immunotherapy of Cancer 29th Annual Meeting
Collection date 2014.
Copyright © 2014 Lin et al.; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
PMCID: PMC4288556
